Oorsprong van het eerstegraads netwerk van Samuel Menghistu
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bloomwell Group GmbH
 Bloomwell Group GmbH Pharmaceuticals: OtherHealth Technology Bloomwell Group GmbH is a holding German company for medical cannabis companies and potentially for companies in a recreational market that may be legal in the future. The company is based in Frankfurt, Germany. The company's mission is to build, acquire and invest in ESG healthcare companies along the entire value chain, with the exception of cultivation. Bloomwell Group relies on a patient-centric D2C approach to set up a strong, revolutionizing and streamlined patient journey to change healthcare for the better. The company was founded in 2020 by Niklas Kouparanis, Samuel Menghistu. Niklas Kouparanis has been the CEO since 2020.
3
| Holding Company | Pharmaceuticals: Other | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Samuel Menghistu via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Farmako GmbH
 Farmako GmbH Pharmaceuticals: MajorHealth Technology Farmako GmbH operates as a holding company, which engages in the sale and distribution of pharmaceutical cannabis products. It also specializes in the research and development of new therapies using cannabis-based drugs. The company was founded by Niklas Kouparanis, Patrick Schmitt, and Sebastian Diemer on September 12, 2018 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Chief Executive Officer |
Statistieken
Internationaal
| Duitsland | 2 |
Sectoraal
| Health Technology | 2 |
Operationeel
| Chief Executive Officer | 2 |
| Founder | 2 |
| Director/Board Member | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Niklas Kouparanis | 2 |
| Reinhard Meier | 1 |
| Boris Jordan | 0 |
- Beurs
- Insiders
- Samuel Menghistu
- Bedrijfsconnecties
